Raymond James Financial Inc. Purchases New Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Raymond James Financial Inc. bought a new position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) during ...
Market Inference2d
Zimmer Biomet Stock Jumps 2.1% – Potential for Further Gains?
Zimmer Biomet's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 4 ...
Medical Design & Outsourcing2d
SES Force-4 will exhibit at DeviceTalks Boston
SES Force-4, a division of premium engineering services provider Stress Engineering Services, will exhibit at DeviceTalks ...
Atria Investments Inc Acquires 2,929 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Atria Investments Inc boosted its holdings in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 54.0% during ...
FMIBlog6d
Global Orthopedic Consumables Market to Reach USD 60.9 Billion by 2034 Amid Rising Demand for Advanced Surgical Solutions | FMI
The global orthopedic consumables market is set to witness significant growth, with market valuation expected to surge from USD 44.0 billion in 2024 to USD 60.9 billion by 2034, according to recent ...
Zimmer Biomet Holdings, Inc. (ZBH): A Bull Case Theory
We came across a bullish thesis on Zimmer Biomet Holdings, Inc. (ZBH) on Twitter by QuestforYield. In this article, we will ...
BioSpace14d
Zimmer Biomet to Present at the 27th Annual Barclays Healthcare Conference
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our ...
Sokolove Law16d
Zimmer Biomet Hip Replacement Lawsuit
In July 2024, Zimmer Biomet issued a voluntary recall of the CPT Hip System Femoral Stem 12/14 Neck Taper to update the product’s instructions with this risk. However, the company plans to continue ...
Pharmaceutical Technology17d
Medigene and EpimAb to develop T cell engagers for solid tumours
T-cell receptors have the ability to identify both intracellular and extracellular targets that are displayed on cancer cells. Credit: PeopleImages.com – Yuri A/Shutterstock. Medigene and EpimAb ...
Investing17d
Zimmer Biomet names Jehanzeb Noor as new strategy and innovation chief
The company’s innovative approach integrates digital and robotic technologies, data analytics, and artificial intelligence into its comprehensive product portfolio. With over 90 years of experience ...
TMCnet17d
Zimmer Biomet Appoints Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer
Mr. Noor holds a Master of Science with a focus on Product Development, a Bachelor of Science in Finance and a Bachelor of Science in Mechanical Engineering, all from the Massachusetts Institute of ...
Nasdaq17d
Zimmer Biomet Appoints Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer
Feb. 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings ... In addition, he will have oversight of the research and product development organizations, inclusive of new product and service development ...